Biomedical, Clinical & Life Sciences

No applicants // Limit: 1 // Tickets Available: 1 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites institutions to submit applications to participate in the Neonatal Research Network (NRN).

This Funding Opportunity Announcement (FOA) invites applications for NRN Clinical Centers; a separate FOA invites applications for a NRN Data Coordinating Center.

No applicants // Limit: 1 // Tickets Available: 1 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites institutions to submit applications to participate in the Neonatal Research Network (NRN).

This Funding Opportunity Announcement (FOA) invites applications for a NRN Data Coordinating Center; a separate FOA invites applications for NRN Clinical Centers.

No applicants // Limit: 1 // Tickets Available: 1 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites institutions to submit applications to participate in the Maternal-Fetal Medicine Units (MFMU) Network.

This Funding Opportunity Announcement (FOA) invites applications for a MFMU Network Data Coordinating Center; a separate FOA invites applications for MFMU Network Clinical Centers.

No applicants // Limit: 1 // Tickets Available: 1 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites institutions to submit applications to participate in the Maternal-Fetal Medicine Units (MFMU) Network.

This Funding Opportunity Announcement (FOA) invites applications for MFMU Network Clinical Centers; a separate FOA invites applications for a MFMU Network Data Coordinating Center.

No applicants // Limit: 1 // Tickets Available: 1 

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

No applicants // Limit: 1 // Tickets Available: 1 

Brain Research Foundation is inviting UArizona to nominate one senior faculty member to submit a Letter of Intent for the 2023 Scientific Innovations Award (SIA). The objective of the program is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and result in major grant applications and funding as well as significant publications in high impact journals.

To be eligible, the nominee must be a full-time associate professor/full professor working in the area of neuroscience and brain function in health and disease. Current major NIH or other peer-reviewed funding is preferred but evidence of such funding in the past three years is essential. The grant period is for two years totaling $150,000. The support focus is for new research projects of the highest scientific merit. 

T. Sawyer

No applicants // Limit: 1 // Tickets Available: 1 

Fiscal year (FY) 2022 Accelerating Cancer Screening (AxCS) funding will support health centers to increase equitable access to cancer screening and referral for care and treatment by enhancing education, case management, outreach, and other enabling services, in partnership or coordination with National Cancer Institute (NCI)-designated Cancer Centers that will deploy outreach specialists and patient navigators for populations served by health centers. 

M. Dodson

UArizona is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator or Accelerator. Institutions may not submit nominations in multiple award types in a single grant cycle.

To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes, is inspiring a new generation of diabetes researchers.

Eligibility for Accelerator Awards (ACC)
Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Amount Upper: $1,625,000USD
Award Term: Up to 5 years
Maximum Funding: $325,000/year

Eligibility for Initiator Award (INI)
Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Amount Upper: $1,625,000USD
Award Term: Up to 7 year
Maximum Funding: Up to $100,000/year in Phase 1, Up to $325,000/year in Phase 2

May 24, 2022 update: The program for 2022 has been discontinued by the external sponsor. RDS has concluded the internal competition. Contact RDS with questions

UArizona may submit one nomination.

The mission of the Foundation is to support early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease. Any domestic biomedical institution, whether solely research or educational, is invited to submit one candidate for the Mallinckrodt Board's consideration.

Each institution is allowed to submit one proposal. Applicants should be in the first to fourth year of their tenure track faculty position and not have current R01 funding. Grants are usually $60,000 and funding commences on October 1. No indirect costs are allowed. Salary is acceptable.